Publications

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

Title

Author

Year

Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.

Kositz, C; VASILEVA, H; MOHAMMED, N; Achan, J; Dabira, ED; D'ALESSANDRO, U; BRADLEY, J; MARKS, M;

2024

Malaria journal, (2024).23 1 10.1186/s12936-024-04878-2.

Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.

Ochoge, M; Futa, AC; Umesi, A; Affleck, L; Kotei, L; Daffeh, B; Saidy-Jah, E; Njie, A; Oyadiran, O; Edem, B; Jallow, M; Jallow, E; Donkor, SA; Tritama, E; Abid, T; Jones, KA V; Mainou, BA; Konz, JO; Fix, A; Gast, C; CLARKE, E;

2024

Lancet (London, England), (2024).403 10432 10.1016/S0140-6736(23)02844-1.

Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to <i>M. tuberculosis</i> infection.

Nieuwenhuizen, NE; Nouailles, G; SUTHERLAND, JS; Zyla, J; Pasternack, AH; Heyckendorf, J; Frye, BC; Höhne, K; Zedler, U; Bandermann, S; Abu Abed, U; Brinkmann, V; Gutbier, B; Witzenrath, M; Suttorp, N; Zissel, G; Lange, C; Ritvos, O; Kaufmann, SH E; CAPNETZ Study group,; DZIF TB study group,;

2024

mBio, (2024).15 3 10.1128/mbio.03408-23.

Access to respiratory syncytial virus preventive tools for neonates and infants in Europe.

Pley, C; KAMPMANN, B;

2024

The Lancet. Infectious diseases, (2024).24 4 10.1016/s1473-3099(24)00084-7.

Managing hypertension in rural Gambia and Kenya: Protocol for a qualitative study exploring the experiences of patients, health care workers, and decision-makers [version 1; peer review: 1 approved with reservations].

DIALLO, BA; Hassan, S; Kagwanja, N; Oyando, R; Badjie, J; Mumba, N; PRENTICE, AM; Perel, P; Etyang, A; Nolte, E; Tsofa, B;

2024

NIHR open research, (2024).4, 10.3310/nihropenres.13523.1.

Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study.

Minier, N; Guingané, AN; Okeke, E; Sinkala, E; Johannessen, A; Andersson, MI; Davwar, P; Desalegn, H; Duguru, M; Fall, F; Mboup, S; Maponga, T; Matthews, PC; Ramírez Mena, A; NDOW, G; Orlien, SM S; Riches, N; Seydi, M; Sonderup, M; Spearman, CW; Stockdale, AJ; Taljaard, J; Vinikoor, M; Wandeler, G; Lemoine, M; ... Sombié, R.

2024

The lancet. Gastroenterology & hepatology, (2024).9 4 10.1016/s2468-1253(23)00449-1.

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.

Marshall, AD; Willing, AR; Kairouz, A; Cunningham, EB; Wheeler, A; O'Brien, N; Perera, V; Ward, JW; Hiebert, L; Degenhardt, L; Hajarizadeh, B; Colledge, S; Hickman, M; Jawad, D; Lazarus, JV; Matthews, GV; Scheibe, A; Vickerman, P; Dore, GJ; Grebely, J; Global HCV and HIV Treatment Restrictions Group,;

2024

The lancet. Gastroenterology & hepatology, (2024).9 4 10.1016/s2468-1253(23)00335-7.

Towards an intelligent malaria outbreak warning model based intelligent malaria outbreak warning in the northern part of Benin, West Africa.

GBAGUIDI, GJ; Topanou, N; Filho, WL; Ketoh, GK;

2024

BMC public health, (2024).24 1 10.1186/s12889-024-17847-w.

Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy.

Buekens, P; Berrueta, M; Ciapponi, A; Bardach, A; Mazzoni, A; Rodriguez-Cairoli, F; Gottlieb, SL; KAMPMANN, B; PARKER, EP K; Xiong, X; Zaraa, S; Stergachis, A;

2024

Vaccine, (2024).42 7 10.1016/j.vaccine.2024.02.012.

Sources and pathways by which low-grade inflammation contributes to anaemia in rural African children from 6 months to 3 years of age: study protocol for observational studies IDeA 1 and IDeA 2.

Ledger, E; Verhoef, H; Jallow, A; Cunningham, N; PRENTICE, A; CERAMI, C;

2024

medRxiv (2024). 10.1101/2024.02.09.24301930.